The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $974,697 in first-year total cost, median $487,349.
Most frequent study sections
- Special Emphasis Panel[ZDA1 JXR-G (04)]2
Most frequent institutions
- J. DAVID GLADSTONE INSTITUTES1
- UNIVERSITY OF NEBRASKA MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2016 | Targeting lysine methylation for latency reversal in HIV-infected drug users1R01DA043142-01 | OTT, MELANIE MARIA | J. DAVID GLADSTONE INSTITUTES, CA | $598,447 | ZDA1 |
| 2016 | HIV Tat & cocaine-mediated alterations in microglial migration & activation involve epigenetic reulation of miRNAs1R01DA043138-01 | BUCH, SHILPA J.GUO, MINGLEIHU, GUOKU | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $376,250 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.